Focus:

Cancer Channel Featured Story TOP

Add to Favorites Subscribe Share
fbshare-Cancer Channel Featured Story TOP

Showing results

110 of 95
  • Embargo expired:
    21-Aug-2019 5:00 PM EDT

Article ID: 717580

Unprecedented Therapy Found Effective for Blood Cancer Patients With No Treatment Options

Mount Sinai Health System

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

Released:
16-Aug-2019 11:00 AM EDT
Newswise: Antibiotics Exposure Linked to Increased Colon Cancer Risk

Article ID: 717661

Antibiotics Exposure Linked to Increased Colon Cancer Risk

Johns Hopkins Medicine

In an extensive “data mining” analysis of British medical records, researchers at the Johns Hopkins Kimmel Cancer Center conclude that taking even a single course of antibiotics might boost—albeit slightly—the risk of developing colon cancer—but not rectal cancer—a decade later. The findings, reported in the August 20 issue of the journal Gut, highlight the need for judicious use of this broad category of drugs, which are frequently improperly or overprescribed, the report authors say.

Released:
21-Aug-2019 9:00 AM EDT
Newswise: CWRU School of Nursing Awarded $2.14M National Cancer Institute Grant

Article ID: 717595

CWRU School of Nursing Awarded $2.14M National Cancer Institute Grant

Case Western Reserve University

With a $2.14 million grant from the National Cancer Institute (NCI), researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University will measure whether an approach that uses simulation or experiential learning can affectively teach family caregivers not only the skills to take better care of their patient, but better care of their own emotional and physical health amid such incredible stress.

Released:
19-Aug-2019 10:00 AM EDT
Newswise: Henry Ford Cancer Institute Enrolls First Patient in World’s Largest Brain Cancer Clinical Trial

Article ID: 717461

Henry Ford Cancer Institute Enrolls First Patient in World’s Largest Brain Cancer Clinical Trial

Henry Ford Health System

A next-generation clinical trial program and the first-ever adaptive platform trial for brain cancer, GBM AGILE is a move away from the traditional, one-size-fits-all approach to clinical trials – a major step forward for Precision Medicine.

Released:
14-Aug-2019 11:05 AM EDT
Newswise: Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients
  • Embargo expired:
    11-Jul-2019 11:00 AM EDT

Article ID: 715470

Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients

Perelman School of Medicine at the University of Pennsylvania

Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they’ve completed locally ablative therapy almost tripled the median progression-free survival compared to the historical average.

Released:
9-Jul-2019 11:00 AM EDT
Newswise: Immunotherapy drug found safe in treating cancer patients with HIV

Article ID: 713855

Immunotherapy drug found safe in treating cancer patients with HIV

Fred Hutchinson Cancer Research Center

The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.

Released:
3-Jun-2019 2:05 PM EDT
Newswise: Mouse Studies Show Minimally Invasive Route Can Accurately Administer Drugs to Brain
  • Embargo expired:
    1-May-2019 1:00 PM EDT

Article ID: 711911

Mouse Studies Show Minimally Invasive Route Can Accurately Administer Drugs to Brain

Johns Hopkins Medicine

In experiments in mice, Johns Hopkins researchers say they have developed a technique that facilitates the precise placement of cancer drugs at their intended targets in the brain. This approach pairs a technique that guides a catheter through the brain’s arteries with positron emission technology (PET) scans to precisely place cancer drugs at their intended targets in the brain. If future studies show this image-guided drug delivery method is safe and effective in humans, the researchers say it could improve outcomes for historically difficult-to-treat and often lethal brain cancers, such as glioblastoma.

Released:
29-Apr-2019 9:00 AM EDT
Newswise: A Resolution for Good Health

Article ID: 705827

A Resolution for Good Health

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute experts share more about the importance of preventative screenings for colorectal and lung cancers.

Released:
26-Dec-2018 10:35 AM EST
Newswise: New research explores policies on timely breast cancer diagnosis for underserved women

Article ID: 705785

New research explores policies on timely breast cancer diagnosis for underserved women

University of Illinois at Chicago

Delays in diagnosis and use of under-resourced health centers account for most racial and ethnic disparities when it comes to a timely breast cancer diagnosis, according to a new study.

Released:
20-Dec-2018 4:05 PM EST
Newswise: Genome offers clues to esophageal cancer disparity

Article ID: 705750

Genome offers clues to esophageal cancer disparity

Michigan Medicine - University of Michigan

A change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this population, a new study finds. It suggests a possible target for prevention strategies, which preliminary work suggests could involve flavonoids derived from cranberries.

Released:
20-Dec-2018 10:05 AM EST

Showing results

110 of 95

Chat now!